화학공학소재연구정보센터
검색결과 : 7건
No. Article
1 Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance (vol 553, pg 91, 2018)
Zhang JF, Bu X, Wang HZ, Zhu YS, Geng Y, Nihira NT, Tan YY, Ci YP, Wu F, Dai XP, Guo JP, Huang YH, Fan CQ, Ren SC, Sun YH, Freeman GJ, Sicinski P, Wei WY
Nature, 571(7766), 2019
2 Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance
Zhang JF, Bu X, Wang HZ, Zhu YS, Geng Y, Nihira NT, Tan YY, Ci YP, Wu F, Dai XP, Guo JP, Huang YH, Fan CQ, Ren SC, Sun YH, Freeman GJ, Sicinski P, Wei WY
Nature, 553(7686), 91, 2018
3 Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent
Kamphorst AO, Wieland A, Nasti T, Yang S, Zhang R, Barber DL, Konieczny BT, Daugherty CZ, Koenig L, Yu K, Sica GL, Sharpe AH, Freeman GJ, Blazar BR, Turka LA, Owonikoko TK, Pillai RN, Ramalingam SS, Araki K, Ahmed R
Science, 355(6332), 1423, 2017
4 Defining CD8(+) T cells that provide the proliferative burst after PD-1 therapy
Im SJ, Hashimoto M, Gerner MY, Lee J, Kissick HT, Urger MCB, Shan Q, Hale JS, Lee J, Nasti TH, Sharpe AH, Freeman GJ, Germain RN, Nakaya HI, Xue HH, Ahmed R
Nature, 537(7620), 417, 2016
5 Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin MM, Zhang XL, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, Mulder GE, Toebes M, Vesely MD, Lam SSK, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce EL, Schumacher TN, Aebersold R, Rammensee HG, Melief CJM, Mardis ER, Gillanders WE, Artyomov MN, Schreiber RD
Nature, 515(7528), 577, 2014
6 Maintenance of Human T-Cell Anergy - Blocking of IL-2 Gene-Transcription by Activated RAP1
Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM
Science, 278(5335), 124, 1997
7 Prevention of T-Cell Anergy by Signaling Through the Gamma(C) Chain of the IL-2 Receptor
Boussiotis VA, Barber DL, Nakarai T, Freeman GJ, Gribben JG, Bernstein GM, Dandrea AD, Ritz J, Nadler LM
Science, 266(5187), 1039, 1994